Go Deep
Natural Capsules Limited
Natural Capsules Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,666 | -6.9 | 0.78 | 0.49 | 166.74 |
| Oct 2026 | 21,650 | -6.7 | 0.75 | 0.49 | 160.01 |
Natural Capsules Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 487,119,000.0 | 584,533,000.0 | 377,456,000.0 | 458,027,000.0 |
| Net Profit | -57,438,000.0 | -49,768,000.0 | -71,171,000.0 | -69,890,000.0 |
| EPS | -5.5 | -4.8 | -6.9 | -6.8 |
Natural Capsules Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,830,881,000.0 | 1,641,512,000.0 | 1,512,897,000.0 | 1,647,196,000.0 | — |
| Net Profit | -246,634,000.0 | 6,174,000.0 | 55,535,000.0 | 184,462,000.0 | — |
| EPS | -23.8 | 0.6 | 6.0 | 19.9 | — |
Natural Capsules Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 4,241,578,000.0 | 4,193,515,000.0 | 3,765,252,000.0 | 2,887,612,000.0 | — |
| Total Liabilities | 1,894,357,000.0 | 1,621,905,000.0 | 1,477,210,000.0 | 1,405,150,000.0 | — |
| Total Equity | 2,216,355,000.0 | 2,329,361,000.0 | 2,038,001,000.0 | 1,232,261,000.0 | — |
Owes vs Owns
Natural Capsules Limited owed ₹0.45 for every ₹1 it owned in Mar 2026, down from ₹0.49 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.45× | 0.39× | 0.39× | 0.49× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Natural Capsules Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 1.1%Receivables 16.8%Inventory 6.2%Fixed assets (tangible) 65.5%Long-term investments 0.6%Other assets 9.7%
How it's funded — Mar 2026
Short-term debt 14.1%Long-term debt 12.9%Payables 13.0%Other liabilities 4.7%Shareholders' equity 55.3%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4.8 | 5.2 | 13.0 | 6.6 |
| Receivables | 71.4 | 62.2 | 54.5 | 52.1 |
| Inventory | 26.3 | 25.5 | 19.0 | 8.8 |
| Fixed assets (tangible) | 278.0 | 283.6 | 246.1 | 183.4 |
| Intangible assets | 0.0 | 0.0 | 0.5 | 1.1 |
| Long-term investments | 2.7 | 2.7 | 2.7 | 0.0 |
| Other assets | 41.0 | 40.1 | 40.8 | 36.8 |
| Liabilities & equity | ||||
| Short-term debt | 59.6 | 47.4 | 41.1 | 26.1 |
| Long-term debt | 54.7 | 56.4 | 67.9 | 70.4 |
| Payables | 55.3 | 38.5 | 30.4 | 27.4 |
| Other liabilities | 19.8 | 19.9 | 8.3 | 16.6 |
| Shareholders' equity | 234.7 | 257.2 | 228.8 | 148.2 |
| Net tangible assets | 221.6 | 232.9 | 203.3 | 122.1 |
Natural Capsules Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 109,170,000.0 | 267,520,000.0 | -83,538,000.0 | 172,167,000.0 | — |
| Investing Activities | -107,653,000.0 | -444,847,000.0 | -725,861,000.0 | -1,046,295,000.0 | — |
| Financing Activities | -6,202,000.0 | 161,668,000.0 | 817,169,000.0 | 874,920,000.0 | — |